Bleomycin in germ cell tumor therapy: Not all regimens are created equal

Journal of Clinical Oncology

Volumn 15, Issue 5, 1997, Pages 1717-1719

  Bajorin, Dean F ^a   Bosl, George J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; VINBLASTINE;

BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; EDITORIAL; GERM CELL TUMOR; HUMAN; LUNG TOXICITY; MAJOR CLINICAL STUDY; METASTASIS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RAYNAUD PHENOMENON;

EID: 0030947120     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.5.1717     Document Type: Editorial

References (11)